AML

(redirected from acute myelocytic leukemia)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to acute myelocytic leukemia: acute lymphocytic leukemia, acute myelogenous leukemia, Acute myeloid leukaemia

Adjustable Rate Mortgage

A mortgage with an interest rate that changes periodically. Generally speaking, an adjustable rate mortgage is linked to some major benchmark rate; for example, the interest rate may be stated as "LIBOR + 1%." The mortgage may or may not have a cap on how much the interest rate can rise or fall, or on how often the interest rate may change. Very often, the initial interest rate for an adjustable-rate mortgage is lower than that for a fixed-rate mortgage. This allows more people to qualify for an adjustable-rate mortgage; however, this kind of mortgage can be risky because the interest rate (and therefore the monthly payment) can rise unexpectedly. Indeed the prevalence of ARMs has been blamed for the housing bubble in the mid-2000s and the subsequent recession. See also: Credit Crunch, Teaser Rate.

Anti-Money Laundering

Any law or regulation requiring an institution to perform due diligence on potential clients to ensure that it is not aiding in a money laundering scheme. If the institution does not conduct due diligence properly, it may be held legally liable for the money laundering activities. These regulations were an important part of the USA PATRIOT Act.

AML

See adjustable mortgage loan.
References in periodicals archive ?
Figure 6: Acute Myelocytic Leukemia, Global, Clinical Pipeline Phase II by Primary Endpoints, 2010 29
Figure 7: Acute Myelocytic Leukemia, Global, Clinical Pipeline Phase II by Secondary Endpoints, 2010 30
A snapshot of the global therapeutic scenario for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia).
A review of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
OTCQB: RCHA) is a biopharmaceutical company developing a treatment for Acute Myelocytic Leukemia (AML)/white blood cell elevation, Myelodysplastic Syndromes (MDS), Hodgkin's Lymphoma and other blood related diseases.
An Overview of Pipeline Products for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Therapeutics under Investigation by Universities/Institutes
Full browser ?